Regulus Therapeutics Inc.
RGLS · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10 | -$13 | -$14 | -$11 |
| Dep. & Amort. | $0 | $0 | -$1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $2 | $2 | $2 |
| Change in WC | -$3 | -$1 | $3 | -$2 |
| Other Non-Cash | -$0 | -$0 | -$0 | -$1 |
| Operating Cash Flow | -$11 | -$12 | -$9 | -$12 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$5 | $0 |
| Inv. Sales/Matur. | $22 | $24 | $24 | $0 |
| Other Inv. Act. | -$0 | $0 | $0 | $0 |
| Investing Cash Flow | $22 | $24 | $19 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $1 | $0 | -$1 |
| Stock Issued | $0 | -$94 | $0 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $92 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | -$1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $11 | $12 | $9 | -$12 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $39 | $26 | $17 | $30 |
| End Cash | $50 | $39 | $26 | $17 |
| Free Cash Flow | -$10 | -$12 | -$9 | -$12 |